Vanderbilt Institute For Infection Immunology And Inflammation
-
Probing pathogen antibiotic resistance
Understanding how bacteria evolve resistance to antibiotics and host stresses could guide the development of more effective antimicrobial therapeutics. Read MoreSep 17, 2020
-
“Nur” target may aid arthritis treatment
Vanderbilt immunologists have discovered that the protein Nur77 is part of a control mechanism that guards against autoimmunity in natural killer T cells. Read MoreJul 13, 2020
-
Recurrent UTIs linked to hidden reservoir
Bacterial invasion of vaginal cells sets up a protective niche and a reservoir for recurrent urinary tract infections, Vanderbilt researchers demonstrated. Read MoreJul 9, 2020
-
New space bolsters infectious disease and immunology discovery
The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home. Read MoreJul 9, 2020
-
The adaptable anthrax bacterium
Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil. Read MoreMay 14, 2020
-
Looking through MudPIT for protein interactions
The identification of novel protein interactions and sites of modification in proteins involved in mRNA translation adds to understanding of a process that is an important therapeutic target. Read MoreFeb 25, 2020
-
Zinc uptake by a deadly pathogen
The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses. Read MoreJan 13, 2020
-
Imaging host-pathogen battle for metal
An unprecedented view of bacterial products within infected tissues opens new opportunities to explore infection biology and devise novel therapeutic strategies. Read MoreOct 31, 2019
-
Pua lands NIH Director’s New Innovator Award
Heather Pua, MD, PhD, one of 60 investigators to receive the 2019 NIH Director’s New Innovator Award, will explore a novel type of cell signaling by RNAs in allergic airway inflammation. Read MoreOct 1, 2019
-
Host-microbe interactions in the gut
Vanderbilt investigators demonstrated that intestinal cells promote beneficial microbe behavior — the findings support developing microbiota-based therapies for intestinal health. Read MoreAug 13, 2019
-
Intestinal immune cell interactions
Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases. Read MoreJul 30, 2019
-
Madhur receives Presidential Early Career Award
Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers. Read MoreJul 18, 2019
-
Discovery of new “checkpoint” points to new cancer immunotherapy option
An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer. Read MoreFeb 21, 2019
-
Six projects garner Microbiome Venture Fund awards
Six faculty-led teams have received 2018 Microbiome Venture Fund awards to pursue projects related to the broad category of microbiomes—the totality of microbes in or on an environment. Read MoreAug 14, 2018